Company · CIK 0001534120 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Avalo Therapeutics, Inc. · AVTX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 SForm 4 → | Sep 18, 4:10 pm EDT | Christopher Ryan SullivanChief Financial Officer | 12,394 | $16.33 | $202,437 | 39,900 | −23.7% | 10b5-1 |
| Sep 16, 2026 MForm 4 → | Sep 18, 4:10 pm EDT | Christopher Ryan SullivanChief Financial Officer | 12,394 | $9.88 | $122,453 | 52,294 | — | 10b5-1 |
| Sep 10, 2026 SForm 4 → | Sep 11, 4:10 pm EDT | Christopher Ryan SullivanChief Financial Officer | 10,185 | $17.62 | $179,457 | 39,900 | −20.3% | 10b5-1 |
| Sep 10, 2026 MForm 4 → | Sep 11, 4:10 pm EDT | Christopher Ryan SullivanChief Financial Officer | 10,185 | $8.04 | $81,887 | 50,085 | — | 10b5-1 |
| Aug 28, 2026 SForm 4 → | Sep 1, 4:38 pm EDT | Mittie DoyleChief Medical Officer | 679 | $20.00 | $13,580 | 51,776 | −1.29% | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Sep 1, 4:38 pm EDT | Mittie DoyleChief Medical Officer | 679 | $8.04 | $5,459 | 52,455 | — | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 19, 4:10 pm EDT | Christopher Ryan SullivanChief Financial Officer | 72,725 | $19.94 | $1,450,419 | 39,900 | −64.6% | 10b5-1 |
| Aug 17, 2026 MForm 4 → | Aug 19, 4:10 pm EDT | Christopher Ryan SullivanChief Financial Officer | 71,852 | $9.88 | $709,898 | 70,931 | — | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 19, 4:10 pm EDT | Mittie DoyleChief Medical Officer | 1,000 | $20.00 | $20,000 | 51,776 | −1.89% | 10b5-1 |
| Aug 17, 2026 MForm 4 → | Aug 19, 4:10 pm EDT | Mittie DoyleChief Medical Officer | 1,000 | $12.65 | $12,650 | 52,776 | — | 10b5-1 |
| Aug 11, 2026 SForm 4 → | Aug 12, 4:10 pm EDT | Jennifer RileyChief Strategy Officer | 2,655 | $19.59 | $52,012 | 37,041 | −6.69% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 4:10 pm EDT | Mittie DoyleChief Medical Officer | 679 | $20.00 | $13,580 | 51,776 | −1.29% | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 12, 4:10 pm EDT | Mittie DoyleChief Medical Officer | 679 | $8.04 | $5,459 | 52,455 | — | 10b5-1 |
| Jul 27, 2026 SForm 4 → | Jul 29, 4:05 pm EDT | Mittie DoyleChief Medical Officer | 1,000 | $20.00 | $20,000 | 51,776 | −1.89% | 10b5-1 |
| Jul 27, 2026 MForm 4 → | Jul 29, 4:05 pm EDT | Mittie DoyleChief Medical Officer | 1,000 | $12.65 | $12,650 | 52,776 | — | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jul 2, 4:05 pm EDT | Mittie DoyleChief Medical Officer | 4,654 | $20.00 | $93,080 | 51,776 | −8.25% | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 4:05 pm EDT | Mittie DoyleChief Medical Officer | 4,654 | $10.89 | $50,672 | 56,430 | — | 10b5-1 |
| Jun 23, 2026 SForm 4 → | Jun 25, 5:24 pm EDT | Mittie DoyleChief Medical Officer | 1,450 | $18.00 | $26,100 | 51,776 | −2.72% | 10b5-1 |
| Jun 23, 2026 MForm 4 → | Jun 25, 5:24 pm EDT | Mittie DoyleChief Medical Officer | 1,450 | $8.04 | $11,658 | 53,226 | — | 10b5-1 |
| Jun 10, 2026 FForm 4 → | Jun 12, 4:43 pm EDT | Jennifer RileyChief Strategy Officer | 588 | $13.10 | $7,703 | 39,696 | — | |
| Jun 10, 2026 FForm 4 → | Jun 12, 4:41 pm EDT | Paul VarkiChief Legal Officer | 1,081 | $13.10 | $14,161 | 32,576 | — | |
| Jun 10, 2026 FForm 4 → | Jun 12, 4:36 pm EDT | Christopher Ryan SullivanChief Financial Officer | 138 | $13.10 | $1,808 | 40,773 | — | |
| Jun 10, 2026 FForm 4 → | Jun 12, 4:26 pm EDT | Mittie DoyleChief Medical Officer | 1,084 | $13.10 | $14,200 | 51,776 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 MForm 4 → | Sep 18, 4:10 pm EDT | Christopher Ryan SullivanChief Financial Officer | 12,394 | — | — | 83,848 | — | 10b5-1 |
| Sep 10, 2026 MForm 4 → | Sep 11, 4:10 pm EDT | Christopher Ryan SullivanChief Financial Officer | 10,185 | — | — | 105,815 | — | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Sep 1, 4:38 pm EDT | Mittie DoyleChief Medical Officer | 679 | — | — | 113,734 | — | 10b5-1 |
| Aug 17, 2026 MForm 4 → | Aug 19, 4:10 pm EDT | Christopher Ryan SullivanChief Financial Officer | 71,852 | — | — | 96,242 | — | 10b5-1 |
| Aug 17, 2026 MForm 4 → | Aug 19, 4:10 pm EDT | Mittie DoyleChief Medical Officer | 1,000 | — | — | 123,750 | — | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 12, 4:10 pm EDT | Mittie DoyleChief Medical Officer | 679 | — | — | 114,413 | — | 10b5-1 |
| Jul 27, 2026 MForm 4 → | Jul 29, 4:05 pm EDT | Mittie DoyleChief Medical Officer | 1,000 | — | — | 124,750 | — | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 4:05 pm EDT | Mittie DoyleChief Medical Officer | 4,654 | — | — | 115,092 | — | 10b5-1 |
| Jun 30, 2026 AForm 4 → | Jul 2, 4:05 pm EDT | Ron M PhilipDirector | 69 | $15.04 | $1,038 | 69 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 4:05 pm EDT | Kevin Robert LindDirector | 1,105 | $15.04 | $16,619 | 1,105 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 4:05 pm EDT | Rita JainDirector | 1,080 | $15.04 | $16,243 | 1,080 | — | |
| Jun 23, 2026 MForm 4 → | Jun 25, 5:24 pm EDT | Mittie DoyleChief Medical Officer | 1,450 | — | — | 116,871 | — | 10b5-1 |
| Jun 23, 2026 AForm 4 → | Jun 25, 5:24 pm EDT | Ron M PhilipDirector | 40,200 | — | — | 40,200 | — | |
| Jun 2, 2026 AForm 4 → | Jun 4, 4:10 pm EDT | Kevin Robert LindDirector | 20,100 | — | — | 20,100 | — | |
| Jun 2, 2026 AForm 4 → | Jun 4, 4:10 pm EDT | Samantha TruexDirector | 20,100 | — | — | 20,100 | — | |
| Jun 2, 2026 AForm 4 → | Jun 4, 4:10 pm EDT | Gilla KaplanDirector | 20,100 | — | — | 20,100 | — | |
| Jun 2, 2026 AForm 4 → | Jun 4, 4:10 pm EDT | Aaron KantoffDirector | 20,100 | — | — | 20,100 | — | |
| Jun 2, 2026 AForm 4 → | Jun 4, 4:10 pm EDT | Michael Thomas HeffernanDirector | 29,500 | — | — | 29,500 | — | |
| Jun 2, 2026 AForm 4 → | Jun 4, 4:10 pm EDT | Rita JainDirector | 20,100 | — | — | 20,100 | — |